COHERUS BIOSCIENCES INC (CHRS)

US19249H1032 - Common Stock

1.51  -0.06 (-3.82%)

Premarket: 1.5 -0.01 (-0.66%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
304.34M257.24M211.00M326.60M475.80M
Minority Interest Expense
N/AN/AN/AN/A0.00
Cost Of Goods
168.26M158.99M70.10M57.60M37.70M
Gross Profit
136.08M98.25M141.00M269.00M438.20M
Operating Expenses
263.80M296.55M397.80M532.80M281.80M
Research and Development
98.47M105.84M199.40M363.10M142.80M
Selling, General, and Administrative Expenses
165.34M190.72M198.50M169.70M139.10M
Operating Income
-127.73M-198.30M-256.90M-263.90M156.30M
Interest Income/Expense
-32.43M-40.54M-32.50M-23.00M-21.20M
Other Income/Expense
6.29M5.47M3.80M-300.00K600.00K
Non Recurring Items
153.42M-4.90M-6.20MN/AN/A
Income Before Taxes
-450.00K-238.27M-291.80M-287.10M135.70M
Income Tax
0.00-380.00K0.000.003.50M
Net Income
-450.00K-237.89M-291.80M-287.10M132.20M
EBITDA
-122.39M-194.51M-253.20M-260.40M159.20M
 
Per Share Data
EPS Diluted Total Ops
-0.09-2.53-3.76-3.811.58
Non GAAP EPS
-1.09-2.02-3.03-1.151.69
 
Statistics
Gross Profit Margin
44.71%38.19%66.82%82.36%92.10%
Profit Margin
-0.15%-92.48%-138.29%-87.91%27.78%
Operating Profit Margin
-41.97%-77.09%-121.75%-80.80%32.85%

All data in USD

Charts